Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy
Gregory R. Pond et al.
BJU INTERNATIONAL (2012)
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
Daniel Keizman et al.
ONCOLOGIST (2012)
CXCR4 Expression in Prostate Cancer Progenitor Cells
Anna Dubrovska et al.
PLOS ONE (2012)
Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse
Seung Wook Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species
Rajasubramaniam Shanmugam et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
James W. Denham et al.
LANCET ONCOLOGY (2011)
IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR
A. Rojas et al.
ONCOGENE (2011)
MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 Subjects
Chen Mao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
Junxia Min et al.
NATURE MEDICINE (2010)
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Yi Lu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality
Jennifer Rider Stark et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Inflammatory Processes of Prostate Tissue Microenvironment Drive Rat Prostate Carcinogenesis: Preventive Effects of Celecoxib
Narayanan K. Narayanan et al.
PROSTATE (2009)
Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: A multicenter study
Raina N. Fichorova et al.
ANALYTICAL CHEMISTRY (2008)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
NF-κB2/p52 Enhances Androgen-Independent Growth of Human LNCaP Cells Via Protection From Apoptotic Cell Death and Cell Cycle Arrest Induced by Androgen-Deprivation
Nagalakshmi Nadiminty et al.
PROSTATE (2008)
Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer
Shinako Araki et al.
CANCER RESEARCH (2007)
Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: Modification by lymphotoxin alpha
Xin Liu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model
Rajasubramaniam Shanmugam et al.
PROSTATE (2006)
Interleukin 6, a nuclear factor-κB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-κB inhibition by PS-1145 enhances docetaxel antitumor activity
Josep Domingo-Domenech et al.
CLINICAL CANCER RESEARCH (2006)
Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
J Domingo-Domenech et al.
BRITISH JOURNAL OF CANCER (2005)
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men
H Rennert et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Expression of NF-κB in prostate cancer lymph node metastases
H Ismail et al.
PROSTATE (2004)
Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate
C Sweeney et al.
CLINICAL CANCER RESEARCH (2004)
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk
JF Xu et al.
NATURE GENETICS (2002)
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M Bolla et al.
LANCET (2002)
Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
SY Huang et al.
ONCOGENE (2001)
Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia
MJ Putzi et al.
UROLOGY (2000)
Share Paper
